ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Comment on "Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice".

Ling Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.